| Source: |
| Type: |
| ACADS - Acyl-CoA Dehydrogenase, Short Chain Abbreviation: ACADS, SCAD Type: Mitochondrial fatty-acid β-oxidation enzyme / acyl-CoA dehydrogenase Function: ACADS encodes short-chain acyl-CoA dehydrogenase, a mitochondrial flavoprotein that catalyzes the first dehydrogenation step in β-oxidation of short-chain fatty acyl-CoAs, particularly butyryl-CoA. ACADS contributes to fatty-acid energy metabolism, mitochondrial function, and metabolic homeostasis. Cancer: ↓ Reduced ACADS expression has been reported in cancers including colorectal cancer and hepatocellular carcinoma and is associated with tumor progression and poorer prognosis. Experimental restoration of ACADS can suppress proliferation, migration, and invasion. ACADS may also promote antitumor immunity by enhancing mitochondrial DNA leakage and cGAS-STING signaling, while ACADS deficiency can contribute to an immunosuppressive tumor microenvironment. |
| 7779- | ISL, | Isoliquiritigenin-mediated miR-23a-3p inhibition activates PGC-1α to alleviate alcoholic liver injury |
| - | in-vivo, | Alcohol, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1695 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid